5/24/2022CASI and Tianshi Enter Sublicense Deal for Anti-Cd38 mAb CID-103 in Au...

5/23/2022Fujifilm Completes Construction of Bioprocessing Innovation & Collabor...

5/23/2022Novartis's Promacta Approved in China for Expanded Use in Children Ag...

5/23/2022Sinohealth: Chinese Hospital Drug Sales Fell 4% in Q1/2022

5/23/2022IQVIA: Chinese Hospital Drug Market Rose 4.2% in Q1/2021

5/23/2022VerImmune and Fosun Pharma Enter Licensing Deal for Virus-inspired Pa...

5/23/2022Biopharma in China: The Emerging Global Force of Domestic Suppliers

5/20/2022U.S., European Firms Rethink China Investment After Lockdowns

5/20/2022VerImmune and Fosun in Deal for VerImmune's ViP Platform as Novel Im...

5/20/2022Recent Executive Moves

5/19/2022China Approves Bayer/MSD's Verquvo (vericiguat) for Chronic Heart Fail...

5/19/2022CTTQ and Symphogen Enter Pact for Global Rights of Latter's mAb Sym022

5/19/2022APAC Hospital Priorities 2022: Strategic Implications for Pharma Compa...

5/19/2022Pediatric Drug Development A New Investment Area in China (PharmaDJ's ...

5/17/2022SMEI: Chinese Public Medical Institution Drug Sales Surged 7.2% in 202...

5/17/2022NHSA Completes Building of Unified National BMI Information Platform

5/17/2022433 Listed Chinese Pharma Companies Report Their Annual Performance in...

5/16/2022Visus and Zhaoke Enter Exclusive Licensing Deal for Brimochol PF and C...

5/16/2022Kelun Out-licenses Anticancer Drug Candidate to MSD in $1.4B Deal

5/16/2022Pfizer Leads April Approvals in China with Two JAK Inhibitors (PharmaD...

5/13/2022Green Valley Aborts Trial of Its Alzheimer's Drug amid Fundraisng and ...

5/13/2022Review of Leading Listed Chinese Pharma Cos by R&D Spending in 2021

5/13/2022SMEI: Top 20 Pharma Cos by Hospital Drug Sales in 2021

5/12/2022Henlius and Eurofarma Entered into a License Deal for Three Henlius P...

5/12/2022Merck KGaA Warns of Volatile 2022 Thanks to War in Ukraine and Fresh C...

5/12/2022China Resources in Talks to Take Sihuan Pharma Private At $3B Valuatio...

5/11/2022China Rolls Out Five Year Plan to Develop $3.28 Trillion Bioeconomy ...

5/11/2022NMPA Issues the 14th FYP for Drug Regulatory Network Safety and IT Bui...

5/11/2022Review of Top 10 Listed Chinese Biotech Firms by R&D Spending in 2021

5/10/2022NMPA Issues Two Guidelines for TCM Registration and Evaluation

Page:77/367 Total number of articles:10986: [First][<<] [75] [76] [77] [78] [79] [>>] [End]